세계의 타액 채취 및 진단 시장 : 기회, 성장 동력, 산업 동향 분석 및 예측(2024-2032년)

The Global Saliva Collection and Diagnostics Market will showcase an 8.3% CAGR between 2024 and 2032, driven by the growing appeal of non-invasive saliva-based tests as a convenient and acceptable alternative to traditional diagnostic methods. According to the U.S. National Institutes of Health (NIH), non-invasive diagnostic technologies, including saliva-based tests, will grow at an annual rate of 9.5% from 2023 to 2028 due to their convenience and accuracy.

Additionally, the increasing prevalence of chronic diseases and the rising demand for early disease detection are bolstering the adoption of saliva diagnostics. The convenience of at-home testing and the growing focus on personalized medicine supports market expansion.

The saliva collection and diagnostics market is sorted based on the site of collection, application, end-use, and region.

The parotid gland collection segment will grow at a notable pace over the study period, driven by superior diagnostic yield compared to other collection sites. The parotid gland produces a higher concentration of certain biomarkers, which enhances the sensitivity and specificity of diagnostic tests. This improved diagnostic performance is crucial for accurately detecting and monitoring various health conditions, including oral diseases and systemic disorders. Additionally, the growing emphasis on precision medicine is pushing for more accurate and reliable diagnostic methods, further boosting the preference for parotid gland collection.

The forensics segment will hold a significant share of the saliva collection and diagnostics market by 2032, owing to its critical role in criminal investigations and legal proceedings. Saliva samples are used for DNA analysis, which is essential for identifying suspects, and victims, and establishing relationships in forensic cases. The non-invasive nature of saliva collection, combined with its ability to provide valuable genetic information, makes it a preferred method in forensic science. This rising reliance on saliva-based diagnostics for accurate and reliable evidence is promoting advancements in forensic technologies, adding to segment share.

Europe saliva collection and diagnostics market will grow at an impressive pace through 2032, driven by the focus on healthcare innovation and patient-centric solutions. European countries are investing in R and D efforts to enhance diagnostic technologies, fostering advancements in non-invasive testing methods. Additionally, the rising prevalence of chronic diseases and the push for early disease detection are fueling demand for more accessible diagnostic tools. Supportive regulatory frameworks and funding initiatives for diagnostic research bolster market growth. The growing trend towards personalized medicine in Europe will sway the industry dynamics forward.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing infectious diseases among the population
    • 3.2.1.2 Rising demand for non-invasive saliva testing as a replacement of blood testing
    • 3.2.1.3 Technological advancements
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of skilled professionals to operate saliva collection devices
• 3.3 Growth potential analysis
• 3.4 Reimbursement scenario
• 3.5 Regulatory landscape
• 3.6 New emerging therapies
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Site of Collection, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Parotid gland
• 5.3 Submandibular/Sublingual gland
• 5.4 Minor salivary glands

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Disease diagnostics
  • 6.2.1 Infectious diseases
  • 6.2.2 Genetic testing
  • 6.2.3 Other disease diagnostics
• 6.3 Forensics
• 6.4 Research

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Hospitals and dental clinics
• 7.2 Diagnostic laboratories
• 7.3 Pharmaceutical and biotechnology companies
• 7.4 Research Institutes
• 7.5 Forensic laboratories

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Akonni Biosystems, Inc.
• 9.3 Autogen, Inc.
• 9.4 Meridian Bioscience, Inc.
• 9.5 Neogen Inc
• 9.6 Norgen Biotek Corp
• 9.7 OraSure Technologies, Inc
• 9.8 Porex
• 9.9 Salimetrics, LLC.
• 9.10 Sarstedt AG and Co.KG
• 9.11 Spectrum Solutions, LLC.
• 9.12 Takara Bio, Inc.
• 9.13 Thermo Fisher Scientific, Inc.
• 9.14 Wuxi NEST Biotechnology Co., Ltd
• 9.15 ZRT Laboratory
• 9.16 Zymo Research Corporation